AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
26min chapter
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
CD20 x CD3 Bispecific Antibodies in Non-Hodgkin Lymphoma Management
The speakers explore the potential efficacy and side effect profiles of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. They discuss the optimal partner for combination therapy, address the issue of susceptibility to infection and response to vaccination, and emphasize the importance of educating patients and staff and implementing prophylaxis measures.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode